Results 161 to 170 of about 12,578,048 (280)

Prevalence of heparin-induced PF4-heparin antibodies in hemodialysis patients [PDF]

, 1998
Schiffl, H., Sitter, T., Banas, B., Sitter, Thomas, Schiffl, Helmut, Spannagl, M.   +5 more
core   +1 more source

Illuminating point‐of‐care diagnostics with aggregation‐induced emission biosensors

FlexMat, EarlyView.
This review highlights the application of aggregation‐induced emission luminogens (AIEgens) in point‐of‐care (POC) diagnostics for disease biomarker detection. It systematically examines a range of biosensing platforms, including lateral flow immunoassays, microfluidic chips, and electrochemiluminescence sensors, alongside their utility in detecting ...
Danni Hu, Yubing Hu, Dong Wang, Ben Zhong Tang   +3 more
wiley   +1 more source

Comparative safety of direct oral anticoagulants and low-molecular-weight heparin in patients with venous thromboembolism and cancer in Europe. [PDF]

J Comp Eff Res
Brodin E, Young A, Langer F, Alikhan R, Timo L, Lambrelli D, Nordstrom B, Booth A, Graham S, Mokgokong R, Jenkins A, Chaves J, Dai F, Subash R, Lehne M, Ghiani M, Mevius A, Fliegner D, Gottsäter A.   +18 more
europepmc   +1 more source

Postoperative Hemoglobin and Transfusion Rates Do Not Influence Revision of Head and Neck Free Flap in a Cohort of 259 Patients

Head &Neck, EarlyView.
ABSTRACT Introduction Recent literature advocates restrictive transfusion thresholds (Hb < 7 g/dL). The aim of this study was to evaluate if postoperative hemoglobin levels and transfusions influence Free Flap Revision (FFR). Methods This single center retrospective study included all patients who underwent head and neck surgery with free flap ...
Olivier Gilbert, Agnès Dupret‐Bories, Olivier Staes, Guillaume Ducos, Luc Nguyen Van Phi, Claire Cabos, Muriel Picard, Charline Berthier, Mathilde Morisseau, Emilien Chabrillac   +9 more
wiley   +1 more source

Perioperative low molecular weight heparin bridging in aortic mechanical heart valve patients undergoing endoscopic procedures. [PDF]

Endosc Int Open
Grewal TS, Godoy AD, Bhagirath V, Casanegra AI, Tafur A, McNiven Fontani A, Ghorbanzadeh A, Houghton DE, Abdulrehman J, Galanaud JP, Sordo LD, Alnuaimi M, Daniels PR, Carlin S, Sadozai Y, Barkun A, Douketis J.   +16 more
europepmc   +1 more source

Safety and Effectiveness of Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparin for Cancer-Associated Thrombosis: A Systematic Review and Meta-analysis. [PDF]

Drug Saf
Kang W, Lam BPY, Lau RTL, Li STH, Wu K, Wei Y, Yang Y, Lee KJ, Huang C, Yan VKC, Yiu HHE, Lee SF, Helali AE, Lee VHF, Chan SL, Hui RYM, Lam KO, Chan EW.   +17 more
europepmc   +1 more source

Andexanet alfa for the reversal of the low-molecular-weight heparin enoxaparin. [PDF]

Res Pract Thromb Haemost
van Haaps TF, Benz AP, Xu L, Middeldorp S, Eikelboom JW, Milling TJ, Crowther M, Holer L, Nolan S, Ladenvall P, Lu G, Coppens M.   +11 more
europepmc   +1 more source

Gout in pregnancy: Obstetric and neonatal outcomes

International Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 349-355, April 2025.
Abstract Objective The pregnancy, delivery, and neonatal outcomes of pregnancies complicated by gout have yet to be evaluated in a population‐based study. We sought to evaluate the obstetric and neonatal outcomes in pregnant patients with gout using a national population database.
Sam Amar, Ahmad Badeghiesh, Haitham Baghlaf, Michael H. Dahan   +3 more
wiley   +1 more source

Safety of Fondaparinux After Low-Molecular-Weight Heparin in Bleeding-Complicated High-Risk Pregnancies: A PSM Cohort Study. [PDF]

Int J Womens Health
Yang H, Gao Y, Song X.
europepmc   +1 more source

The utility of serum markers in the conservative management of placenta accreta spectrum (PAS) by leaving the placenta in situ in women with high‐grade PAS

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To investigate the association between serum markers and successful conservative management of patients with placenta accreta spectrum (PAS). Methods This was a retrospective case–control study where patients with high‐grade PAS between 2011 and 2025 undergoing conservative leaving the placenta in situ were included.
Ammar Al Naimi, Charlotte Wiesmann, Doerthe Brueggmann, Anna Elisabeth Hentrich, Eileen Deuster, Samira Catharina Hoock, Lukas Jennewein, Frank Louwen   +7 more
wiley   +1 more source